Remove Collaboration Remove Contract research organization Remove Strategic partnership
article thumbnail

DCAT Week 2025: Key Takeaways & Industry Advancements

Frost & Sullivan

As pharmaceutical innovation continues to reshape the industry, key focuses at DCAT Week 2025 included manufacturing capacity expansion, supply chain resilience, digital transformation, and strategic collaborations. Samsung Biologics leveraged its DCAT participation to establish multiple new industry partnerships.

article thumbnail

Southern Star Research Applauded by Frost & Sullivan for Delivering Comprehensive Clinical Trial Solutions and Its Competitive Strategies

Frost & Sullivan

13 th February 2025 Frost & Sullivan recently analyzed the biotechnology contract research organization (CRO) industry and, based on its findings, recognizes Southern Star Research with the 2024 Asia-Pacific Competitive Strategy Leadership Award. SAN ANTONIO, TX.

Biotech 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Transformational Growth Leadership: An Exclusive Interview with Yvonne Lungershausen, CEO, Avance Clinical

Frost & Sullivan

Innovating for Growth: The Future of Biotech CROs The biotech Contract Research Organization (CRO) industry is undergoing a rapid transformation, driven by technological advancements, globalization, and evolving patient needs. We have formed strategic partnerships to pilot AI-driven efficiencies.

Biotech 52
article thumbnail

Novotech Awarded Frost & Sullivan’s 2024 Global Company of the Year Award for Its Leadership and Excellence in Biotech CRO Services

Frost & Sullivan

San Antonio, TX — 14 th October 2024 — Frost & Sullivan recently conducted an in-depth analysis of the biotech contract research organization (CRO) industry and based on its findings, has awarded Novotech the 2024 Global Company of the Year Award.

Biotech 52